Haematologica (Jun 2018)
Long-term management of leukocyte adhesion deficiency type III without hematopoietic stem cell transplantation
- Paul Saultier,
- Sarah Szepetowski,
- Matthias Canault,
- Céline Falaise,
- Marjorie Poggi,
- Pierre Suchon,
- Vincent Barlogis,
- Gérard Michel,
- Stéphane Loyau,
- Martine Jandrot-Perrus,
- Jean-Claude Bordet,
- Marie-Christine Alessi,
- Hervé Chambost
Affiliations
- Paul Saultier
- APHM, La Timone Children’s Hospital, Department of pediatric hematology and oncology, Marseille, France;Aix Marseille Univ, INSERM, INRA, C2VN, France
- Sarah Szepetowski
- APHM, La Timone Children’s Hospital, Department of pediatric hematology and oncology, Marseille, France
- Matthias Canault
- Aix Marseille Univ, INSERM, INRA, C2VN, France
- Céline Falaise
- APHM, La Timone Children’s Hospital, Department of pediatric hematology and oncology, Marseille, France;APHM, CHU Timone, Laboratory of Hematology, Marseille, France;APHM, CHU Timone, French national reference center for inherited platelet disorders (CRPP), Marseille, France
- Marjorie Poggi
- Aix Marseille Univ, INSERM, INRA, C2VN, France
- Pierre Suchon
- Aix Marseille Univ, INSERM, INRA, C2VN, France;APHM, CHU Timone, Laboratory of Hematology, Marseille, France
- Vincent Barlogis
- APHM, La Timone Children’s Hospital, Department of pediatric hematology and oncology, Marseille, France;APHM, La Timone Children’s Hospital, French national reference center for primary immune deficiencies (CEREDIH), Marseille, France
- Gérard Michel
- APHM, La Timone Children’s Hospital, Department of pediatric hematology and oncology, Marseille, France;APHM, La Timone Children’s Hospital, French national reference center for primary immune deficiencies (CEREDIH), Marseille, France
- Stéphane Loyau
- Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Univ Paris Diderot, Sorbonne Paris Cité, France
- Martine Jandrot-Perrus
- Laboratory of Vascular Translational Science, U1148 Institut National de la Santé et de la Recherche Médicale (INSERM), Univ Paris Diderot, Sorbonne Paris Cité, France
- Jean-Claude Bordet
- HCL, Hôpital Cardiologique Louis Pradel, Unité d’Hémostase Biologique, Bron, France;EAM 4609 Hémostase et cancer, Université Claude Bernard Lyon 1, France
- Marie-Christine Alessi
- Aix Marseille Univ, INSERM, INRA, C2VN, France;APHM, CHU Timone, Laboratory of Hematology, Marseille, France;APHM, CHU Timone, French national reference center for inherited platelet disorders (CRPP), Marseille, France
- Hervé Chambost
- APHM, La Timone Children’s Hospital, Department of pediatric hematology and oncology, Marseille, France;Aix Marseille Univ, INSERM, INRA, C2VN, France
- DOI
- https://doi.org/10.3324/haematol.2017.186304
- Journal volume & issue
-
Vol. 103,
no. 6
Abstract
No abstracts available.